Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • anniemoo
    Junior Member
    • Jan 2013
    • 1

    MiSeq Reporter Metagenomics Workflow

    Hey there

    Has anyone used the MiSeq Reporter Metagenomics Workflow before? Is it worth it? Or is QIIME the absolute way to go?

    My problem with the MSR workflow is the fact that I don't know what happens between purity filtering fastq file generation and the start of the taxonomic classification (in terms of quality trimming/chimera checking etc)...no info is available as it is all proprietary and we are struggling to get anything from them.

    Any help/ideas/thoughts/comments welcome.
  • microgirl123
    Senior Member
    • Jun 2012
    • 199

    #2
    We tell all of our users that it's nice and generates pretty pie charts, but you have to actually do the data analysis yourself. There is absolutely no documentation about how the data is quality checked available. It's also not comparing your data to a full 16s dataset - just an "Illumina curated" subset of Greengenes (I think). I have no idea how you could publish data from MSR. It's great for a quick undergrad poster presentation, but other than that I don't think it's worth much unless Illumina is much more forthcoming about the analysis.

    Comment

    • BioGenomics
      Member
      • Apr 2009
      • 25

      #3
      Miseq Reporter Metagenomics and summary

      Hi all,

      here is some info on Illumina's read classifier for metagenomics: http://support.illumina.com/help/Bas...thods%7C_____1


      I was wondering if anybody had a script/tool to merge all the individual results from MSR Metagenomics into a nice summary table to be used in VEGAN or Calypso ? In BaseSpace, the aggregate results csv is what you need, but it is not implemented in MSR tool...

      thanks !

      Greg

      Comment

      • thermophile
        Senior Member
        • Apr 2015
        • 243

        #4
        I completely agree with microgirl. Why spend thousands generating data if you are going to trust a pie chart from a black box.

        I prefer mothur to qiime.
        Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.

        Comment

        • lac302
          Member
          • Dec 2012
          • 64

          #5
          ^^agreed. mothur is much easier to implement

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2



            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            Introduction

            The systematic characterization
            ...
            Today, 10:07 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          28 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          38 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-07-2026, 11:05 AM
          0 responses
          35 views
          0 reactions
          Last Post SEQadmin2  
          Working...